ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is a subtype of breast cancer defined by the negative expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor-2 (HER2), accounting for 15–20% of breast cancers [2].